Sinopharm
1099.HK
#2152
Rank
A$10.99 B
Marketcap
$3.52
Share price
-2.02%
Change (1 day)
-14.39%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): A$3.61 Billion

According to Sinopharm's latest financial reports the company's current earnings are A$84.39 Billion. a decrease over its 2022 earnings that were of A$5.00 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 A$4.96 B-0.73%
2022 A$5.00 B-1.72%
2021A$5.08 B11.7%
2020A$4.55 B18.44%
2019A$3.84 B10.85%
2018A$3.46 B3.05%
2017A$3.36 B36.48%
2016A$2.46 B7.11%
2015A$2.30 B12.38%
2014A$2.04 B25.05%
2013A$1.63 B22.54%
2012A$1.33 B35.43%
2011A$0.98 B52.24%
2010A$0.64 B30.99%
2009A$0.49 B60.59%
2008A$0.30 B48.29%
2007A$0.20 B123.29%
2006A$93.13 M